Back to results
US 2025/0320307 A1Published application
Anti-4-1bb nanobodies
AssigneeLaNova Medicines Limited Company
InventorsRunsheng Li, Wentao Huang
Life of this patent
Estimating the term…
Abstract
Provided are anti-4-1BB nanobodies and bispecific or multispecific antibodies that incorporate the nanobodies. Methods of using the antibodies for treating and diagnosing diseases such as cancer are also provided.
Claims9
A single domain antibody or a polypeptide comprising the single domain antibody, wherein the single domain antibody has binding specificity to the human 4-1BB protein and comprises a complementarity determining region 1 (CDR1), a CDR2 and a CDR3, wherein the CDR1 comprises the amino acid sequence of SEQ ID NO:
- 18, the CDR2 comprises the amino acid sequence of SEQ ID NO:58, and the CDR3 comprises the amino acid sequence of SEQ ID NO:32.
Dependencies are inferred from the claim text.